Research
Hormonal
Low-GI diets are associated with modest to clinically important benefits for cardiovascular disease (CVD) risk factors and diabetes management, including lower total cholesterol and improved glycemic control.
Prioritize foods with a lower Glycemic Index (GI) to help manage blood sugar and cholesterol levels. This is particularly beneficial for individuals with diabetes or those at risk for heart disease.
GoodQualifiesMEDIUM confidence
Accordingly it has been proposed that GI classification of foods and drinks could be useful to help consumers make ‘healthy food choices’... meta-analysis by Opperman et al. (2004) supports the value of low-GI foods to lower total cholesterol and improve metabolic control of diabetes.
Why this rating
Based on multiple intervention studies and meta-analyses cited.
Source
Glycaemic index methodology
Fred Brouns et al. · Nutrition Research Reviews · 2005
DOI 10.1079/nrr2005100
narrative_reviewCited 1,046×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Standardized Glycemic Index (GI) measurement requires a minimum of 10 healthy subjects and 2-3 repeated trials of the reference food (glucose) to achieve statistically valid precision.Strong
- The method of calculating 'available carbohydrate' significantly impacts GI values, with newer methods accurately measuring resistant starch (RS) preventing the overestimation of GI in foods with indigestible fibers.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →